Quick Takeaways
- Adage Capital Management, L.P. filed SCHEDULE 13G for Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share (CDTX).
- Disclosed ownership: 9%.
- Date of event: 31 Mar 2025.
Adage Capital Management, L.P. - 31 Mar 2025 SCHEDULE 13G Report for Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share (CDTX)
- Filing Manager
- Adage Capital Management, L.P.
- Reporting Manager
- Adage Capital Management, L.P.
- Symbol
- CDTX
- Shares outstanding
- 10,951,327 shares
- Disclosed Ownership
- 990,000 shares
- Ownership
- 9%
- Form type
- SCHEDULE 13G
- Filing time
- 12 May 2025, 09:04:22 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 12 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Adage Capital Management, L.P. disclosed 9% ownership in Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share (CDTX) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 May 2025, 09:04.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Adage Capital Management, L.P. | 9% | 990,000 | 0 | 990,000 | /s/ Robert Atchinson | Adage Capital Partners LLC, its General Partner, By: Robert Atchinson, its Managing Member | |
| Robert Atchinson | 9% | 990,000 | 0 | 990,000 | /s/ Robert Atchinson | Robert Atchinson, individually | |
| Phillip Gross | 9% | 990,000 | 0 | 990,000 | /s/ Phillip Gross | Phillip Gross, individually |